A judge overstepped in throwing out a class action against two National Australia Bank units over alleged MySuper mismanagement because of a carveout in the Victorian Supreme Court Act which bars class actions involving trust property, an appeals court has heard.
A judge hearing a price-fixing case against steel giant BlueScope has overruled an objection to the ACCCs barrister’s allegedly excessive “eye-rolling” and “scathing and sarcastic” manner during a cross-examination in which the company’s general manager was accused of lying under oath.
An appellate panel of the Fair Work Commission has upheld an aged care worker’s termination for refusing a flu vaccine, but a full-throttled dissent by one commissioner warns Australians against “a system of medical apartheid and segregation”.
A judge has rejected a request for further information on ‘very senior’ Google employees involved in a notification related to a change to Google’s privacy policy which at the centre of court proceedings brought by the ACCC.
A retired financial planner has filed a lawsuit accusinf AMP of using “unfair tactics” to avoid coughing up close to a million dollars allegedly owed under a buyout option exercised in November 2019.
Apple has been hit with a lawsuit alleging iPhone and iPad devices sold in Australia since at least 2014 and equipped with Touch and Face ID technology infringe two patents held by a non-practicing entity.
A judge has issued a stern warning to litigation funders seeking to take a “gamble” on pending court proceedings, ruling they could be held liable for costs if their intervention proves critical to the advancement of the case.
NSW Health wants to amend its defence to an underpayments class action on behalf of 24,000 junior doctors, bringing claims that the lead applicant is barred from seeking compensation for group members under industrial relations law.
Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal vaccine.
US singer Katy Perry can withdraw an admission in a trade mark infringement case that licensing her brand to Target and Myer constituted use, with a judge finding the admission was “not consistent with current law”.